HTR1A and major depressive disorder: Dysregulation of monoamine neurotransmitters, such as serotonin (5-HT) and norepinephrine (NE), which activate cAMP signaling through GPCRs (e.g., 5-HT1A, β-AR), may contribute to reduced cAMP levels in MDD.